Skip to content
FDA drug shortage status

Is Hydromorphone Hydrochloride Injection (Dilaudid) in shortage?

Yes. Hydromorphone Hydrochloride Injection is on FDA’s drug shortage list (unavailable), last updated Nov 18, 2026.

In shortageFDA status
26packages listed
9unavailable

Why it’s in shortage

  • Demand increase for the drug
  • Other

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-10)
    Fresenius Kabi USA, LLCIn shortageAvailableUpdated Nov 18, 2026

    Check wholesalers for inventory

    Maker contact: 888-386-1300

  • Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-15)
    Fresenius Kabi USA, LLCIn shortageAvailableUpdated Nov 18, 2026

    Check wholesaler for inventory

    Maker contact: 888-386-1300

  • Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-50)
    Fresenius Kabi USA, LLCIn shortageUnavailableUpdated Nov 18, 2026

    Next release January 2027. Check wholesalers for inventory.

    Maker contact: 888-386-1300

  • Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-852-25)
    Fresenius Kabi USA, LLCIn shortageUnavailableUpdated Nov 18, 2026

    Next release November 2026. Check wholesalers for inventory.

    Maker contact: 888-386-1300

  • Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 63323-853-25)
    Fresenius Kabi USA, LLCIn shortageUnavailableUpdated Nov 18, 2026

    Next release November 2026. Check wholesalers for inventory.

    Maker contact: 888-386-1300

  • Hydromorphone Hydrochloride, Injection, 4 mg/1 mL (NDC 63323-854-10)
    Fresenius Kabi USA, LLCIn shortageAvailableUpdated Nov 18, 2026

    Check wholesalers for inventory

    Maker contact: 888-386-1300

  • Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-06)
    Fresenius Kabi USA, LLCIn shortageUnavailableUpdated Nov 18, 2026

    Next release November 2026. Check wholesalers for inventory.

    Maker contact: 888-386-1300

  • Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-11)
    Fresenius Kabi USA, LLCIn shortageUnavailableUpdated Nov 18, 2026

    Next release January 2027. Check wholesalers for inventory.

    Maker contact: 888-386-1300

  • Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11)
    Fresenius Kabi USA, LLCIn shortageUnavailableUpdated Nov 18, 2026

    Next release not available at this time. Check wholesalers for inventory.

    Maker contact: 888-386-1300

  • Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11)
    Fresenius Kabi USA, LLCIn shortageAvailableUpdated Nov 18, 2026

    Check wholesalers for inventory

    Maker contact: 888-386-1300

  • Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0018-01)
    Teva Pharmaceuticals USA, Inc.In shortageAvailableUpdated Nov 16, 2026

    Maker contact: 800-545-8800

  • Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0110-03)
    Teva Pharmaceuticals USA, Inc.In shortageAvailableUpdated Nov 16, 2026

    Maker contact: 800-545-8800

  • Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0113-03)
    Teva Pharmaceuticals USA, Inc.In shortageLimited AvailabilityUpdated Nov 16, 2026

    Estimated recovery: November 2026

    Maker contact: 800-545-8800

  • Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31)
    Hospira, Inc., a Pfizer CompanyIn shortageLimited AvailabilityUpdated Nov 9, 2026

    Limited Supply Available. Next Delivery and Estimated Recovery: December 2026

    Maker contact: 844-646-4398

  • Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 0409-1283-37)
    Hospira, Inc., a Pfizer CompanyIn shortageUnavailableUpdated Nov 9, 2026

    Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay

    Maker contact: 844-646-4398

  • Hydromorphone Hydrochloride, Injection, 4 mg/1 mL Syringes (NDC 0409-1304-31)
    Hospira, Inc., a Pfizer CompanyIn shortageAvailableUpdated Nov 9, 2026

    Maker contact: 844-646-4398

  • Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30)
    Hospira, Inc., a Pfizer CompanyIn shortageAvailableUpdated Nov 9, 2026

    Maker contact: 844-646-4398

  • Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-1312-36)
    Hospira, Inc., a Pfizer CompanyIn shortageLimited AvailabilityUpdated Nov 9, 2026

    Limited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay

    Maker contact: 844-646-4398

  • Hydromorphone Hydrochloride, Injection, 0.25 mg/ 0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-1805-01)
    Hospira, Inc., a Pfizer CompanyIn shortageUnavailableUpdated Nov 9, 2026

    Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay

    Maker contact: 844-646-4398

  • Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01)
    Hospira, Inc., a Pfizer CompanyIn shortageAvailableUpdated Nov 9, 2026

    Maker contact: 844-646-4398

  • Hydromorphone Hydrochloride, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-2634-05)
    Hospira, Inc., a Pfizer CompanyIn shortageAvailableUpdated Nov 9, 2026

    Maker contact: 844-646-4398

  • Hydromorphone Hydrochloride, Injection, 500 mg/50 mL (10 mg/mL) (NDC 0409-2634-50)
    Hospira, Inc., a Pfizer CompanyIn shortageAvailableUpdated Nov 9, 2026

    Maker contact: 844-646-4398

  • Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-3365-10)
    Hospira, Inc., a Pfizer CompanyIn shortageAvailableUpdated Nov 9, 2026

    Maker contact: 844-646-4398

  • Hydromorphone Hydrochloride, Injection, 0.5 mg/0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-4264-01)
    Hospira, Inc., a Pfizer CompanyIn shortageLimited AvailabilityUpdated Nov 9, 2026

    Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay

    Maker contact: 844-646-4398

  • Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25)
    Hikma Pharmaceuticals USA, Inc.In shortageAvailableUpdated Oct 14, 2026

    Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.

    Maker contact: 800-631-2174

  • Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-6254-01)
    Hikma Pharmaceuticals USA, Inc.In shortageUnavailableUpdated Oct 14, 2026

    Product temporarily on backorder. Additional lots will be available in the November 2026 timeframe.

    Maker contact: 800-631-2174

FDA recalls of Hydromorphone Hydrochloride

Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Hydromorphone Hydrochloride Injection:

Other forms on FDA’s list

Hydromorphone Hydrochloride Injection shortage questions

Is Hydromorphone Hydrochloride Injection (Dilaudid) in shortage?

Yes. Hydromorphone Hydrochloride Injection is on FDA’s drug shortage list (unavailable), last updated Nov 18, 2026.

Why is there a Hydromorphone Hydrochloride Injection shortage?

FDA records the reason as: Demand increase for the drug; Other.

What should I do if I can’t get Hydromorphone Hydrochloride Injection?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.